Abbott Laboratories 2015 Annual Report Download - page 65

Download and view the complete annual report

Please find page 65 of the 2015 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 80

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80

FINANCIAL REVIEW
63
ABBOTT 2015 ANNUAL REPORT
Valuation of Intangible Assets—Abbott has acquired and contin-
uesto acquire significant intangible assets that Abbott records at
fair value. Transactions involving the purchase or sale of intangi-
ble assets occur with some frequency between companies in the
health care field and valuations are usually based on a discounted
cash flow analysis. The discounted cash flow model requires
assumptions about the timing and amount of future net cash flows,
risk, cost of capital, terminal values and market participants. Each
of these factors can significantly aect the value of the intangible
asset. Abbott engages independent valuation experts who review
Abbotts critical assumptions and calculations for acquisitions of
significant intangibles. Abbott reviews definite-lived intangible
assets for impairment each quarter using an undiscounted net
cash flows approach. If the undiscounted cash flows of an intangi-
ble asset are less than the carrying value of an intangible asset, the
intangible asset is written down to its fair value, which is usually
the discounted cash flow amount. Where cash flows cannot be
identified for an individual asset, the review is applied at the
lowest group level for which cash flows are identifiable. Goodwill
and indefinite-lived intangible assets, which relate to in-process
research and development acquired in a business combination,
arereviewed for impairment annually or when an event that
couldresult in impairment occurs. At December31, 2015, goodwill
amounted to $9.6billion and intangibles amounted to $5.6billion,
and amortization expense in continuing operations for intangible
assets amounted to $601million in 2015, $555million in 2014 and
$588million in 2013. There were no impairments of goodwill in
2015, 2014 or 2013.
Litigation—Abbott accounts for litigation losses in accordance with
FASB Accounting Standards Codification No.450, “Contingencies.
Under ASC No.450, loss contingency provisions are recorded for
probable losses at management’s best estimate of a loss, or when
abest estimate cannot be made, a minimum loss contingency
amount is recorded. These estimates are often initially developed
substantially earlier than the ultimate loss is known, and the
estimates are refined each accounting period as additional infor-
mation becomes known. Accordingly, Abbott is often initially
unable to develop a best estimate of loss, and therefore the mini-
mum amount, which could be zero, is recorded. As information
becomes known, either the minimum loss amount is increased,
resulting in additional loss provisions, or a best estimate can be
made, also resulting in additional loss provisions. Occasionally, a
best estimate amount is changed to a lower amount when events
result in an expectation of a more favorable outcome than previ-
ously expected. Abbott estimates the range of possible loss to be
from approximately $35million to $50million for its legal pro-
ceedings and environmental exposures. Accruals of approximately
$45million have been recorded at December31, 2015 for these
proceedings and exposures. These accruals represent manage-
ments best estimate of probable loss, as defined by FASB ASC
No.450, “Contingencies.
Historically, adjustments to prior years’ rebate accruals have not
been material to net income. Abbott employs various techniques
toverify the accuracy of claims submitted to it, and where possi-
ble, works with the organizations submitting claims to gain insight
into changes that might aect the rebate amounts. For government
agency programs, the calculation of a rebate involves interpreta-
tions of relevant regulations, which are subject to challenge or
change in interpretation.
Income Taxes—Abbott operates in numerous countries where its
income tax returns are subject to audits and adjustments. Because
Abbott operates globally, the nature of the audit items is often very
complex, and the objectives of the government auditors can result
in a tax on the same income in more than one country. Abbott
employs internal and external tax professionals to minimize audit
adjustment amounts where possible. In accordance with the
accounting rules relating to the measurement of tax contingencies,
in order to recognize an uncertain tax benefit, the taxpayer must
be more likely than not of sustaining the position, and the mea-
surement of the benefit is calculated as the largest amount that is
more than 50percent likely to be realized upon resolution of the
benefit. Application of these rules requires a significant amount of
judgment. In the U.S., Abbott’s federal income tax returns through
2011 are settled except for one item, and the income tax returns for
years after 2011 are open. Abbott does not record deferred income
taxes on earnings reinvested indefinitely in foreign subsidiaries.
Pension and Post-Employment BenefitsAbbott oers pension
benefits and post-employment health care to many of its employ-
ees. Abbott engages outside actuaries to assist in the determination
of the obligations and costs under these programs. Abbott must
develop long-term assumptions, the most significant of which are
the health care cost trend rates, discount rates and the expected
return on plan assets. The discount rates used to measure liabilities
were determined based on high-quality fixed income securities
that match the duration of the expected retiree benefits. The health
care cost trend rates represent Abbott’s expected annual rates of
change in the cost of health care benefits and is a forward projec-
tion of health care costs as of the measurement date. A dierence
between the assumed rates and the actual rates, which will not be
known for decades, can be significant in relation to the obligations
and the annual cost recorded for these programs. Low interest
rates have significantly increased actuarial losses for these plans.
AtDecember31, 2015, pretax net actuarial losses and prior service
costs and (credits) recognized in Accumulated other comprehen-
sive income (loss) for Abbotts defined benefit plans and medical
and dental plans were losses of $2.9billion and $70million,
respectively. Actuarial losses and gains are amortized over the
remaining service attribution periods of the employees under the
corridor method, in accordance with the rules for accounting for
post-employment benefits. Dierences between the expected
long-term return on plan assets and the actual annual return are
amortized over a five-year period. Note13 to the consolidated
financial statements describes the impact of a one-percentage
point change in the health care cost trend rate; however, there
canbe no certainty that a change would be limited to only one
percentage point.